AAAAAA

   
Results: 1-8 |
Results: 8
TACROLIMUS-INDUCED CARDIOMYOPATHY - A SYSTEMATIC REVIEW OF OVER 3600 ADULT PATIENTS
Authors: COLEY KC VERRICO MM MCNAMARA DM PARK SC CRESSMAN MD BRANCH RA
Citation: Kc. Coley et al., TACROLIMUS-INDUCED CARDIOMYOPATHY - A SYSTEMATIC REVIEW OF OVER 3600 ADULT PATIENTS, Journal of the American College of Cardiology, 31(2), 1998, pp. 149-149
TEACHING CLINICAL-PHARMACOLOGY AND THERAPEUTICS - SELECTIVE FOR 4TH-YEAR MEDICAL-STUDENTS
Authors: TOFOVIC SP BRANCH RA JACKSON EK CRESSMAN MD KOST CK
Citation: Sp. Tofovic et al., TEACHING CLINICAL-PHARMACOLOGY AND THERAPEUTICS - SELECTIVE FOR 4TH-YEAR MEDICAL-STUDENTS, Journal of clinical pharmacology, 38(8), 1998, pp. 670-679
EFFECT OF LOVASTATIN ON CHOLESTEROL CONTENT OF CARDIAC AND RED-BLOOD-CELL MEMBRANES IN NORMAL AND CARDIOMYOPATHIC HAMSTERS
Authors: POGUE DH MORAVEC CS ROPPELT C DISCH CH CRESSMAN MD BOND M
Citation: Dh. Pogue et al., EFFECT OF LOVASTATIN ON CHOLESTEROL CONTENT OF CARDIAC AND RED-BLOOD-CELL MEMBRANES IN NORMAL AND CARDIOMYOPATHIC HAMSTERS, The Journal of pharmacology and experimental therapeutics, 273(2), 1995, pp. 863-869
EFFICACY AND SAFETY OF PRAVASTATIN IN THE TREATMENT OF PATIENTS WITH TYPE-I OR TYPE-II DIABETES-MELLITUS AND HYPERCHOLESTEROLEMIA
Authors: RASKIN P GANDA OP SCHWARTZ S WILLARD D ROSENSTOCK J LODEWICK PA CRESSMAN MD PHILLIPSON B WEINER B MCGOVERN ME NORTON JM CUCINOTTA GG BEHOUNEK BD
Citation: P. Raskin et al., EFFICACY AND SAFETY OF PRAVASTATIN IN THE TREATMENT OF PATIENTS WITH TYPE-I OR TYPE-II DIABETES-MELLITUS AND HYPERCHOLESTEROLEMIA, The American journal of medicine, 99(4), 1995, pp. 362-369
THE EFFECT OF LOVASTATIN ON THE RENAL MICROCIRCULATION IN EXPERIMENTAL DIABETES
Authors: INMAN SR STOWE NT BROUHARD BH NALLY JV CRESSMAN MD VIDT DG NOVICK AC
Citation: Sr. Inman et al., THE EFFECT OF LOVASTATIN ON THE RENAL MICROCIRCULATION IN EXPERIMENTAL DIABETES, Journal of the American Society of Nephrology, 5(3), 1994, pp. 966-966
LP(A) AND PREMATURE MORTALITY DURING CHRONIC-HEMODIALYSIS TREATMENT
Authors: CRESSMAN MD ABOOD D ONEIL J HOFF HF
Citation: Md. Cressman et al., LP(A) AND PREMATURE MORTALITY DURING CHRONIC-HEMODIALYSIS TREATMENT, Chemistry and physics of lipids, 67-8, 1994, pp. 419-427
LIPID ABNORMALITIES AND END-STAGE RENAL-DISEASE - IMPLICATIONS FOR ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE
Authors: CRESSMAN MD HOOGWERF BJ SCHREIBER MJ COSENTINO FA
Citation: Md. Cressman et al., LIPID ABNORMALITIES AND END-STAGE RENAL-DISEASE - IMPLICATIONS FOR ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE, Mineral and electrolyte metabolism, 19(3), 1993, pp. 180-185
HEMOSTATIC CHARACTERISTICS OF POST CABG PATIENTS AND THE EFFECTS OF 1-MG WARFARIN
Authors: WALENGA JM PIFARRE R CRESSMAN MD HUNNINGHAKE DB FOX NL PROBSTFIELD JL
Citation: Jm. Walenga et al., HEMOSTATIC CHARACTERISTICS OF POST CABG PATIENTS AND THE EFFECTS OF 1-MG WARFARIN, Thrombosis and haemostasis, 69(6), 1993, pp. 1136-1136
Risultati: 1-8 |